Search

  • HOME
  • Search
Original Article
Forty-eight weeks treatment with clevudine 30 mg qd versus lamivudine 100 mg qd for chronic hepatitis B infection: a double-blind randomized study
George KK Lau, Nancy Leung
Clin Mol Hepatol. 2010;16(3):315-320.   Published online September 30, 2010
View: 6803   Download: 40  Crossref: 10
3
Efficacy of 48-week clevudine therapy for chronic hepatitis B
Min Hwan Kim, M.D., Kyung-Ah Kim, M.D., June Sung Lee, M.D., Hyun Woong Lee, M.D. Hyung Joon Kim, M.D. Sang Gu Yun, M.D., Nam-Hoon Kim, M.D., Won Ki Bae, M.D., Young Soo Moon, M.D.
Clin Mol Hepatol. 2009;15(3):331-337.   Published online September 30, 2009
View: 4682   Download: 23  Crossref: 8
Long-term clevudine therapy in nucleos(t)ide-naive and Lamivudine-experienced patients with hepatitis B virus-related chronic Liver diseases
Heon Ju Lee, M.D., Jong Ryul Eun, M.D., Chang Hyeong Lee, M.D. Jae Seok Hwang, M.D. Jeong Ill Suh, M.D. Byung Seok Kim, M.D. Byoung Kuk Jang, M.D. Departments of
Clin Mol Hepatol. 2009;15(2):179-192.   Published online June 30, 2009
View: 5516   Download: 32  Crossref: 12
1
Clevudine therapy in patients with chronic hepatitis B
Kwan Sik Lee
Clin Mol Hepatol. 2009;15(2):119-121.   Published online June 30, 2009
View: 3998   Download: 22  Crossref: 2
1 |

Clinical and
Molecular
Hepatology

Print ISSN: 2287-2728
Online ISSN: 2287-285X


Editorial Office
The Korean Association for the Study of the Liver
Room A1210, 53 Mapo-daero(MapoTrapalace, Dowha-dong), Mapo-gu, Seoul, 04158, Korea
TEL: +82-2-703-0051   FAX: +82-2-703-0071    E-mail: kasl@kams.or.kr
Copyright © The Korean Association for the Study of the Liver.         
COUNTER
TODAY : 1417
TOTAL : 1737425
Close layer